Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
Authors
Keywords
Epithelial ovarian cancer, Histotype, Biomarker, BRCA, Survival, Treatment response
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s12885-018-4242-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relatively Poor Survival of Mucinous Ovarian Carcinoma in Advanced Stage
- (2017) Michiel Simons et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Quality of Life in Ovarian Cancer
- (2017) Kassondra S. Grzankowski et al. Cancer Control
- SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
- (2016) Michelle Moh et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
- (2016) Stefan Kommoss et al. BRITISH JOURNAL OF CANCER
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma
- (2016) Sandra Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
- (2015) Alicia A Tone et al. BMC CANCER
- Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and Management
- (2014) Jubilee Brown et al. Current Oncology Reports
- Integrated analysis of germline and somatic variants in ovarian cancer
- (2014) Krishna L. Kanchi et al. Nature Communications
- Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR Repository
- (2013) Cécile Le Page et al. BIOPRESERVATION AND BIOBANKING
- Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium
- (2013) M. Kobel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Impact of Geographic Variations in Treatment on Outcomes in Ovarian Cancer
- (2013) Ulrike Dehaeck et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study
- (2013) Emine Karabuk et al. Journal of Gynecologic Oncology
- The Different Impact ofBRCAMutations on the Survival of Epithelial Ovarian Cancer Patients: A Retrospective Single-Center Experience
- (2013) D. Lorusso et al. ONCOLOGY
- Advanced Cytoreductive Surgery Workshop Report
- (2012) Krishnansu S. Tewari INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
- (2012) John R. McLaughlin et al. JNCI-Journal of the National Cancer Institute
- Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer
- (2012) Kasmintan A. Schrader et al. OBSTETRICS AND GYNECOLOGY
- Improved Classification of Epithelial Ovarian Cancer
- (2011) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
- (2010) MP Coleman et al. LANCET
- Clinicopathological characteristics of mucinous adenocarcinoma of the ovary
- (2009) Muneaki Shimada et al. GYNECOLOGIC ONCOLOGY
- Inherited Susceptibility to Common Cancers
- (2008) William D. Foulkes NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started